Literature DB >> 22335872

Status of oxidative stress in patients with renal cell carcinoma.

Raguram Ganesamoni1, Shalmoli Bhattacharyya, Santosh Kumar, Ashutosh Chauhan, Uttam K Mete, Mayank M Agarwal, Ravimohan Mavuduru, Gaurav Kaushik, Arup K Mandal, Shrawan K Singh.   

Abstract

PURPOSE: Although oxidative stress is implicated in renal cell carcinoma pathogenesis, to our knowledge changes in oxidative stress parameters in patients who undergo surgery for renal cell carcinoma have not been studied previously. We investigated the status of oxidative stress in patients with renal cell carcinoma.
MATERIALS AND METHODS: Reactive oxygen species, nitric oxide and glutathione were measured in the blood of 68 patients with renal tumor and in 30 age matched normal controls. Levels were measured again 1 week, and 1 and 2 months postoperatively in patients who underwent surgery for renal cell carcinoma. Levels of superoxide dismutase, catalase and lipid peroxidation were measured in tumor tissue and in normal renal parenchyma in 51 patients with renal tumor.
RESULTS: Significantly increased reactive oxygen species and nitric oxide, and decreased glutathione were observed in patients with renal cell carcinoma compared to normal subjects and in patients with benign tumors. Superoxide dismutase and lipid peroxidation were increased and catalase was decreased in tumor tissue compared to normal renal tissue. Oxidative stress correlated with renal cell carcinoma grade and stage but decreased after curative resection. Patients with metastatic disease had persistently increased oxidative stress parameters. Antioxidant enzyme levels in benign tumor tissue were significantly higher than in renal cell carcinoma.
CONCLUSIONS: Patients with renal cell carcinoma have increased oxidative stress, which is effectively alleviated by curative resection. In patients with benign tumors antioxidant defense mechanisms maintain normal redox status. Copyright Â
© 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22335872     DOI: 10.1016/j.juro.2011.11.105

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  16 in total

1.  Serum adenosine deaminase, catalase, and carbonic anhydrase activities in patients with renal cell carcinoma.

Authors:  Necip Pirinççi; Tacettin Yekta Kaya; Mehmet Kaba; Tunç Ozan; İlhan Geçit; Hüseyin Özveren; Hüseyin Eren; Kadir Ceylan
Journal:  Redox Rep       Date:  2016-07-14       Impact factor: 4.412

2.  A pilot investigation of a urinary metabolic biomarker discovery in renal cell carcinoma.

Authors:  Mingxin Zhang; Xiaoyan Liu; Xiang Liu; Hanzhong Li; Wei Sun; Yushi Zhang
Journal:  Int Urol Nephrol       Date:  2019-11-16       Impact factor: 2.370

3.  ROS-activated anticancer prodrugs: a new strategy for tumor-specific damage.

Authors:  Xiaohua Peng; Varsha Gandhi
Journal:  Ther Deliv       Date:  2012-07

4.  Identification of sequence polymorphisms in the displacement loop region of mitochondrial DNA as a risk factor for renal cell carcinoma.

Authors:  Junxia Zhang; Zhanjun Guo; Yaling Bai; Liwen Cui; Shenglei Zhang; Jinsheng Xu
Journal:  Biomed Rep       Date:  2013-05-22

Review 5.  A comprehensive overview of targeted therapy in metastatic renal cell carcinoma.

Authors:  Z Mihaly; Z Sztupinszki; P Surowiak; B Gyorffy
Journal:  Curr Cancer Drug Targets       Date:  2012-09       Impact factor: 3.428

6.  Over-expression of telomere binding factors (TRF1 & TRF2) in renal cell carcinoma and their inhibition by using SiRNA induce apoptosis, reduce cell proliferation and migration invitro.

Authors:  Deeksha Pal; Ujjawal Sharma; Shrawan Kumar Singh; Nandita Kakkar; Rajendra Prasad
Journal:  PLoS One       Date:  2015-03-02       Impact factor: 3.240

7.  Evaluation of oxidative stress status and antioxidant capacity in patients with renal cell carcinoma.

Authors:  Mustafa Aldemir; Ersagun Karaguzel; Emrah Okulu; Ahmet Gudeloglu; Kemal Ener; Asim Ozayar; Ozcan Erel
Journal:  Cent European J Urol       Date:  2015-11-23

8.  Occupational class and risk of renal cell cancer.

Authors:  Masayoshi Zaitsu; Adolfo G Cuevas; Claudia Trudel-Fitzgerald; Takumi Takeuchi; Yasuki Kobayashi; Ichiro Kawachi
Journal:  Health Sci Rep       Date:  2018-05-16

9.  Anti-angiogenic and anti-metastatic activity of synthetic phosphoethanolamine.

Authors:  Adilson Kleber Ferreira; Vanessa Morais Freitas; Débora Levy; Jorge Luiz Mária Ruiz; Sergio Paulo Bydlowski; Rose Eli Grassi Rici; Otaviano Mendonça R Filho; Gilberto Orivaldo Chierice; Durvanei Augusto Maria
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

10.  Mutations in the Mitochondrial ND1 Gene Are Associated with Postoperative Prognosis of Localized Renal Cell Carcinoma.

Authors:  Hakushi Kim; Tomoyoshi Komiyama; Chie Inomoto; Hiroshi Kamiguchi; Hiroshi Kajiwara; Hiroyuki Kobayashi; Naoya Nakamura; Toshiro Terachi
Journal:  Int J Mol Sci       Date:  2016-12-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.